As a practicing pediatrician away from academic circles who read "Therapy for Acute Otitis Media" in the April 1996 issue of the Archives,1 I was a bit dismayed that the study involved the outpatient use of ceftriaxone sodium, one of pediatric's ACE cards for serious, life-threatening infections, to treat otitis media, one of the most common illnesses seen in outpatient pediatrics.
I firmly believe that, if the majority of physicians change their treatment regimens for otitis media to conform to parents' preferences as recommended by the authors, the "most favorite" status of ceftriaxone sodium would be in serious jeopardy.
Certainly, those at Boston University School of Medicine are aware of the rapid emergence of resistant organisms to rampant outpatient use of antibiotics (eg, pneumococci resistance in Spain). I believe that they have a duty to look at the big picture before suggesting using one of our best cannons to
Semones E. Therapy for Acute Otitis Media. Arch Pediatr Adolesc Med. 1996;150(12):1315. doi:10.1001/archpedi.1996.02170370093024
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: